PortfoliosLab logoPortfoliosLab logo
GNOM vs. BOTZ
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

GNOM vs. BOTZ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Global X Genomics & Biotechnology ETF (GNOM) and Global X Robotics & Artificial Intelligence Thematic ETF (BOTZ). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, GNOM achieves a 11.56% return, which is significantly higher than BOTZ's 10.63% return.


GNOM

1D
3.47%
1M
11.33%
YTD
11.56%
6M
9.34%
1Y
57.90%
3Y*
0.45%
5Y*
-9.59%
10Y*

BOTZ

1D
-0.47%
1M
3.43%
YTD
10.63%
6M
9.15%
1Y
28.51%
3Y*
12.50%
5Y*
3.08%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

GNOM vs. BOTZ - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
GNOM
Global X Genomics & Biotechnology ETF
11.56%18.65%-15.99%-8.63%-36.27%-15.93%51.52%1.56%
BOTZ
Global X Robotics & Artificial Intelligence Thematic ETF
10.63%14.17%12.26%38.97%-42.69%8.65%51.92%3.63%

Correlation

The correlation between GNOM and BOTZ is 0.53, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.53

Correlation (3Y)
Calculated over the trailing 3-year period

0.56

Correlation (5Y)
Calculated over the trailing 5-year period

0.63

Correlation (All Time)
Calculated using the full available price history since Apr 11, 2019

0.63

The correlation between GNOM and BOTZ has been stable across timeframes, ranging from 0.53 to 0.63 - a consistent structural relationship.

GNOM vs. BOTZ - Sectors Allocation Comparison


Sectors
GNOM
BOTZ

Healthcare

99.6%
9.0%

Technology

0.4%
31.8%

Basic Materials

-

0.0%

Communication Services

-

4.5%

Consumer Cyclical

-

6.1%

Consumer Defensive

-

0.0%

Energy

-

0.5%

Financial Services

-

0.9%

Industrials

-

48.6%

Real Estate

-

-

Utilities

-

0.0%

Healthcare

GNOM
99.6%
BOTZ
9.0%

Technology

GNOM
0.4%
BOTZ
31.8%

Basic Materials

GNOM

-

BOTZ
0.0%

Communication Services

GNOM

-

BOTZ
4.5%

Consumer Cyclical

GNOM

-

BOTZ
6.1%

Consumer Defensive

GNOM

-

BOTZ
0.0%

Energy

GNOM

-

BOTZ
0.5%

Financial Services

GNOM

-

BOTZ
0.9%

Industrials

GNOM

-

BOTZ
48.6%

Real Estate

GNOM

-

BOTZ

-

Utilities

GNOM

-

BOTZ
0.0%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GNOM vs. BOTZ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GNOM
GNOM Risk / Return Rank: 6262
Overall Rank
GNOM Sharpe Ratio Rank: 6767
Sharpe Ratio Rank
GNOM Sortino Ratio Rank: 6868
Sortino Ratio Rank
GNOM Omega Ratio Rank: 5858
Omega Ratio Rank
GNOM Calmar Ratio Rank: 6666
Calmar Ratio Rank
GNOM Martin Ratio Rank: 5454
Martin Ratio Rank

BOTZ
BOTZ Risk / Return Rank: 3333
Overall Rank
BOTZ Sharpe Ratio Rank: 3434
Sharpe Ratio Rank
BOTZ Sortino Ratio Rank: 3535
Sortino Ratio Rank
BOTZ Omega Ratio Rank: 3232
Omega Ratio Rank
BOTZ Calmar Ratio Rank: 3030
Calmar Ratio Rank
BOTZ Martin Ratio Rank: 3434
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GNOM vs. BOTZ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Global X Genomics & Biotechnology ETF (GNOM) and Global X Robotics & Artificial Intelligence Thematic ETF (BOTZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


GNOMBOTZDifference
Sharpe ratioReturn per unit of total volatility

+0.99

Sortino ratioReturn per unit of downside risk

+1.24

Omega ratioGain probability vs. loss probability

1.35

1.21

+0.14

Calmar ratioReturn relative to maximum drawdown

3.20

1.48

+1.72

Martin ratioReturn relative to average drawdown

9.21

5.08

+4.14

GNOM vs. BOTZ - Sharpe Ratio Comparison

The current GNOM Sharpe Ratio is 2.18, which is higher than the BOTZ Sharpe Ratio of 1.19. The chart below compares the historical Sharpe Ratios of GNOM and BOTZ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


GNOMBOTZDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.18

1.19

+0.99

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.29

0.12

-0.40

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.07

0.44

-0.51

Drawdowns

GNOM vs. BOTZ - Drawdown Comparison

The maximum GNOM drawdown since its inception was -75.00%, which is greater than BOTZ's maximum drawdown of -55.54%. Use the drawdown chart below to compare losses from any high point for GNOM and BOTZ.


Loading charts...

Drawdown Indicators


GNOMBOTZDifference

Max Drawdown

Largest peak-to-trough decline

-75.00%

-55.54%

-19.46%

Max Drawdown (1Y)

Largest decline over 1 year

-18.17%

-19.34%

+1.17%

Max Drawdown (3Y)

Largest decline over 3 years

-46.47%

-29.02%

-17.45%

Max Drawdown (5Y)

Largest decline over 5 years

-72.29%

-55.54%

-16.75%

Current Drawdown

Current decline from peak

-53.90%

-3.72%

-50.18%

Average Drawdown

Average peak-to-trough decline

-40.56%

-18.32%

-22.24%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.30%

5.63%

+0.67%

Volatility

GNOM vs. BOTZ - Volatility Comparison

Global X Genomics & Biotechnology ETF (GNOM) has a higher volatility of 8.77% compared to Global X Robotics & Artificial Intelligence Thematic ETF (BOTZ) at 7.76%. This indicates that GNOM's price experiences larger fluctuations and is considered to be riskier than BOTZ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


GNOMBOTZDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.77%

7.76%

+1.01%

Volatility (6M)

Calculated over the trailing 6-month period

19.72%

18.41%

+1.31%

Volatility (1Y)

Calculated over the trailing 1-year period

26.66%

23.97%

+2.69%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

33.61%

26.72%

+6.89%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

34.19%

25.72%

+8.47%

GNOM vs. BOTZ - Expense Ratio Comparison

GNOM has a 0.50% expense ratio, which is lower than BOTZ's 0.68% expense ratio.


Dividends

GNOM vs. BOTZ - Dividend Comparison

GNOM's dividend yield for the trailing twelve months is around 1.23%, more than BOTZ's 0.59% yield.


PositionTTM2025202420232022202120202019201820172016
BOTZ
Global X Robotics & Artificial Intelligence Thematic ETF
0.59%0.66%0.13%0.20%0.23%0.16%0.19%0.83%1.44%0.01%0.06%
GNOM
Global X Genomics & Biotechnology ETF
1.23%1.37%0.00%0.00%0.00%0.03%0.14%0.00%0.00%0.00%0.00%

Frequently Asked Questions


GNOM and BOTZ have a correlation of 0.53, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

GNOM has higher volatility (8.77%) compared to BOTZ (7.76%). In terms of maximum drawdown, GNOM dropped -75.00% vs BOTZ's -55.54%.

On 5-year performance, BOTZ leads with 3.08% vs -9.59% for GNOM. On fees, GNOM is cheaper at 0.50% per year. On volatility, BOTZ has been the lower-risk option at 7.76%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 5-year period, BOTZ has performed better with a 3.08% return vs -9.59%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

GNOM is cheaper with a 0.50% expense ratio, compared with 0.68% for BOTZ.

GNOM has the higher dividend yield at 1.23%, compared with 0.59% for BOTZ.

GNOM is categorized as Health & Biotech Equities, while BOTZ is Robotics. GNOM tracks Solactive Genomics Index, while BOTZ tracks Indxx Global Robotics & Artificial Intelligence Thematic Index. Their fees differ too: 0.50% for GNOM and 0.68% for BOTZ.

GNOM currently has the higher Sharpe Ratio (2.18 vs 1.19), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for GNOM and BOTZ

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer